{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:55:19Z","timestamp":1781322919794,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100022944","name":"Suzhou Gusu Medical Youth Talent","doi-asserted-by":"publisher","award":["GSWS2024022"],"award-info":[{"award-number":["GSWS2024022"]}],"id":[{"id":"10.13039\/100022944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["SYW2025044"],"award-info":[{"award-number":["SYW2025044"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Appl Genetics"],"DOI":"10.1007\/s13353-026-01085-4","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T02:56:13Z","timestamp":1781319373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic alternative mRNA splicing signature and immune infiltration in prostate cancer"],"prefix":"10.1007","author":[{"given":"Zewen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujiao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicheng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachen","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"1085_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.gde.2017.10.010","volume":"48","author":"AA Agrawal","year":"2018","unstructured":"Agrawal AA, Yu L, Smith PG, Buonamici S (2018) Targeting splicing abnormalities in cancer. Curr Opin Genet Dev 48:67\u201374. https:\/\/doi.org\/10.1016\/j.gde.2017.10.010","journal-title":"Curr Opin Genet Dev"},{"issue":"8","key":"1085_CR53","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/ijc.25841","volume":"129","author":"CL Andersen","year":"2011","unstructured":"Andersen CL, Lamy P, Thorsen K, Kjeldsen E, Wikman F, Villesen P, \u00d8ster B, Laurberg S, \u00d8rntoft TF (2011) Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer. Int J Cancer 129(8):1848\u20131858. https:\/\/doi.org\/10.1002\/ijc.25841","journal-title":"Int J Cancer"},{"key":"1085_CR1","doi-asserted-by":"publisher","unstructured":"Ang MY, Low TY, Lee PY, Wan Mohamad Nazarie WF, Guryev V, Jamal R (2019) Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine. Clin Chim Acta; Int J Clin Chem 498:38\u201346. https:\/\/doi.org\/10.1016\/j.cca.2019.08.010","DOI":"10.1016\/j.cca.2019.08.010"},{"issue":"5","key":"1085_CR17","doi-asserted-by":"publisher","first-page":"e0176880","DOI":"10.1371\/journal.pone.0176880","volume":"12","author":"VES Armero","year":"2017","unstructured":"Armero VES, Tremblay MP, Allaire A, Boudreault S, Martenon-Brodeur C, Duval C, Durand M, Lapointe E, Thibault P, Tremblay-L\u00e9tourneau M, Perreault JP, Scott MS, Bisaillon M (2017) Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas. PLoS ONE 12(5):e0176880. https:\/\/doi.org\/10.1371\/journal.pone.0176880","journal-title":"PLoS ONE"},{"issue":"6","key":"1085_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.tibs.2017.04.001","volume":"42","author":"BJ Blencowe","year":"2017","unstructured":"Blencowe BJ (2017) The Relationship between Alternative Splicing and Proteomic Complexity. Trends Biochem Sci 42(6):407\u2013408. https:\/\/doi.org\/10.1016\/j.tibs.2017.04.001","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"1085_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12885-018-4227-7","volume":"18","author":"E Bowler","year":"2018","unstructured":"Bowler E, Porazinski S, Uzor S, Thibault P, Durand M, Lapointe E, Rouschop KMA, Hancock J, Wilson I, Ladomery M (2018) Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells. BMC Cancer 18(1):355. https:\/\/doi.org\/10.1186\/s12885-018-4227-7","journal-title":"BMC Cancer"},{"issue":"7407","key":"1085_CR52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330\u2013337. https:\/\/doi.org\/10.1038\/nature11252","journal-title":"Nature"},{"issue":"35","key":"1085_CR10","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1038\/s41388-021-01947-7","volume":"40","author":"R Cheng","year":"2021","unstructured":"Cheng R, Xiao L, Zhou W, Jin X, Xu Z, Xu C, Wang P, Luo M, Wang M, Ma K, Cao H, Huang Y, Lin X, Pang F, Li Y, Jiang Q (2021) A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients. Oncogene 40(35):5441\u20135450. https:\/\/doi.org\/10.1038\/s41388-021-01947-7","journal-title":"Oncogene"},{"issue":"9","key":"1085_CR14","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.celrep.2017.08.012","volume":"20","author":"H Climente-Gonz\u00e1lez","year":"2017","unstructured":"Climente-Gonz\u00e1lez H, Porta-Pardo E, Godzik A, Eyras E (2017) The Functional Impact of Alternative Splicing in Cancer. Cell Rep 20(9):2215\u20132226. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.012","journal-title":"Cell Rep"},{"issue":"5","key":"1085_CR41","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/ERC-11-0141","volume":"18","author":"SM Dehm","year":"2011","unstructured":"Dehm SM, Tindall DJ (2011) Alternatively spliced androgen receptor variants. Endocrine-related Cancer 18(5):R183\u2013R196. https:\/\/doi.org\/10.1530\/ERC-11-0141","journal-title":"Endocrine-related Cancer"},{"issue":"12","key":"1085_CR45","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1080\/15548627.2021.1917130","volume":"17","author":"Y Fan","year":"2021","unstructured":"Fan Y, Hou T, Gao Y, Dan W, Liu T, Liu B, Chen Y, Xie H, Yang Z, Chen J, Zeng J, Li L (2021) Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer. Autophagy 17(12):4386\u20134400. https:\/\/doi.org\/10.1080\/15548627.2021.1917130","journal-title":"Autophagy"},{"issue":"11","key":"1085_CR58","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41577-019-0195-7","volume":"19","author":"L Frankiw","year":"2019","unstructured":"Frankiw L, Baltimore D, Li G (2019) Alternative mRNA splicing in cancer immunotherapy. Nat Rev Immunol 19(11):675\u2013687. https:\/\/doi.org\/10.1038\/s41577-019-0195-7","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1085_CR49","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/nar\/gkp050","volume":"37","author":"K Fukumura","year":"2009","unstructured":"Fukumura K, Taniguchi I, Sakamoto H, Ohno M, Inoue K (2009) U1-independent pre-mRNA splicing contributes to the regulation of alternative splicing. Nucleic Acids Res 37(6):1907\u20131914. https:\/\/doi.org\/10.1093\/nar\/gkp050","journal-title":"Nucleic Acids Res"},{"issue":"1\u20132","key":"1085_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jim.2009.06.004","volume":"348","author":"PO Gannon","year":"2009","unstructured":"Gannon PO, Poisson AO, Delvoye N, Lapointe R, Mes-Masson AM, Saad F (2009) Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients. J Immunol Methods 348(1\u20132):9\u201317. https:\/\/doi.org\/10.1016\/j.jim.2009.06.004","journal-title":"J Immunol Methods"},{"issue":"Database issue","key":"1085_CR33","doi-asserted-by":"publisher","first-page":"D125","DOI":"10.1093\/nar\/gks997","volume":"41","author":"M Giulietti","year":"2013","unstructured":"Giulietti M, Piva F, D\u2019Antonio M, De Meo DO, Paoletti P, Castrignan\u00f2 D, D\u2019Erchia T, Picardi AM, Zambelli E, Principato F, Pavesi G, G., Pesole G (2013) SpliceAid-F: a database of human splicing factors and their RNA-binding sites. Nucleic Acids Res 41(Database issue):D125\u2013D131. https:\/\/doi.org\/10.1093\/nar\/gks997","journal-title":"Nucleic Acids Res"},{"key":"1085_CR12","doi-asserted-by":"publisher","unstructured":"He RQ, Zhou XG, Yi QY, Deng CW, Gao JM, Chen G, Wang QY (2018) Cell Physiol biochemistry: Int J Exp Cell Physiol Biochem Pharmacol 48(3):1355\u20131368. https:\/\/doi.org\/10.1159\/000492094. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases","DOI":"10.1159\/000492094"},{"key":"1085_CR32","unstructured":"Heagerty PJ (2013) Survivalroc: time-dependent roc curve estimation from censored survival data"},{"issue":"20","key":"1085_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.21037\/atm.2019.09.65","volume":"7","author":"W Hong","year":"2019","unstructured":"Hong W, Zhang W, Guan R, Liang Y, Hu S, Ji Y, Liu M, Lu H, Yu M, Ma L (2019) Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma. Annals translational Med 7(20):557. https:\/\/doi.org\/10.21037\/atm.2019.09.65","journal-title":"Annals translational Med"},{"issue":"1","key":"1085_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-017-0713-9","volume":"16","author":"D Hormaechea-Agulla","year":"2017","unstructured":"Hormaechea-Agulla D, Gahete MD, Jim\u00e9nez-Vacas JM, G\u00f3mez-G\u00f3mez E, Ib\u00e1\u00f1ez-Costa A, L-L\u00f3pez F, Rivero-Cort\u00e9s E, Sarmento-Cabral A, Valero-Rosa J, Carrasco-Valiente J, S\u00e1nchez-S\u00e1nchez R, Ortega-Salas R, Moreno MM, Tsomaia N, Swanson SM, Culler MD, Requena MJ, Casta\u00f1o JP, Luque RM (2017) The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Mol Cancer 16(1):146. https:\/\/doi.org\/10.1186\/s12943-017-0713-9","journal-title":"Mol Cancer"},{"issue":"11","key":"1085_CR38","doi-asserted-by":"publisher","first-page":"e1195","DOI":"10.1371\/journal.pone.0001195","volume":"2","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Brunet JP, Tamayo P, Golub TR, Mesirov JP (2007) Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE 2(11):e1195. https:\/\/doi.org\/10.1371\/journal.pone.0001195","journal-title":"PLoS ONE"},{"issue":"3","key":"1085_CR24","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3892\/mmr.2017.6910","volume":"16","author":"YQ Huang","year":"2017","unstructured":"Huang YQ, Ling XH, Yuan RQ, Chen ZY, Yang SB, Huang HX, Zhong WD, Qiu SP (2017) miR-30c suppresses prostate cancer survival by targeting the ASF\/SF2 splicing factor oncoprotein. Mol Med Rep 16(3):2431\u20132438. https:\/\/doi.org\/10.3892\/mmr.2017.6910","journal-title":"Mol Med Rep"},{"issue":"6","key":"1085_CR43","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3892\/ijo.2018.4563","volume":"53","author":"ZG Huang","year":"2018","unstructured":"Huang ZG, He RQ, Mo ZN (2018) Prognostic value and potential function of splicing events in prostate adenocarcinoma. Int J Oncol 53(6):2473\u20132487. https:\/\/doi.org\/10.3892\/ijo.2018.4563","journal-title":"Int J Oncol"},{"issue":"10","key":"1085_CR37","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, Liu J, Freeman GJ, Brown MA, Wucherpfennig KW, Liu XS (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"},{"key":"1085_CR26","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.ebiom.2019.11.008","volume":"51","author":"JM Jim\u00e9nez-Vacas","year":"2020","unstructured":"Jim\u00e9nez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, G\u00f3mez-G\u00f3mez E, Fuentes-Fayos AC, Le\u00f3n-Gonz\u00e1lez AJ, S\u00e1ez-Mart\u00ednez P, Alors-P\u00e9rez E, Pedraza-Ar\u00e9valo S, Gonz\u00e1lez-Serrano T, Reyes O, Mart\u00ednez-L\u00f3pez A, S\u00e1nchez-S\u00e1nchez R, Ventura S, Yubero-Serrano EM, Requena-Tapia MJ, Casta\u00f1o JP, Gahete MD, Luque RM (2020) Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine 51:102547. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.008","journal-title":"EBioMedicine"},{"issue":"3","key":"1085_CR20","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.eururo.2014.09.049","volume":"67","author":"T Karantanos","year":"2015","unstructured":"Karantanos T, Evans CP, Tombal B, Thompson TC, Montironi R, Isaacs WB (2015) Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level. Eur Urol 67(3):470\u2013479. https:\/\/doi.org\/10.1016\/j.eururo.2014.09.049","journal-title":"Eur Urol"},{"issue":"24","key":"1085_CR47","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s00018-009-0120-5","volume":"66","author":"H Kuroyanagi","year":"2009","unstructured":"Kuroyanagi H (2009) Fox-1 family of RNA-binding proteins. Cell Mol Life Sci 66(24):3895\u20133907. https:\/\/doi.org\/10.1007\/s00018-009-0120-5","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"1085_CR57","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nm.4165","volume":"22","author":"SC Lee","year":"2016","unstructured":"Lee SC, Abdel-Wahab O (2016) Therapeutic targeting of splicing in cancer. Nat Med 22(9):976\u2013986. https:\/\/doi.org\/10.1038\/nm.4165","journal-title":"Nat Med"},{"key":"1085_CR29","doi-asserted-by":"crossref","unstructured":"Lex A, Gehlenborg, Nils (2014) Points of view: sets and intersections. Nature Methods.","DOI":"10.1038\/nmeth.3033"},{"issue":"12","key":"1085_CR28","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","volume":"20","author":"A Lex","year":"2014","unstructured":"Lex A, Gehlenborg N, Strobelt H, Vuillemot R, Pfister H (2014) UpSet: Visualization of Intersecting Sets. IEEE Trans Vis Comput Graph 20(12):1983\u20131992. https:\/\/doi.org\/10.1109\/TVCG.2014.2346248","journal-title":"IEEE Trans Vis Comput Graph"},{"key":"1085_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.canlet.2017.02.016","volume":"393","author":"Y Li","year":"2017","unstructured":"Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J (2017) Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Cancer Lett 393:40\u201351. https:\/\/doi.org\/10.1016\/j.canlet.2017.02.016","journal-title":"Cancer Lett"},{"key":"1085_CR54","doi-asserted-by":"publisher","first-page":"e37184","DOI":"10.7554\/eLife.37184","volume":"7","author":"J Li","year":"2018","unstructured":"Li J, Choi PS, Chaffer CL, Labella K, Hwang JH, Giacomelli AO, Kim JW, Ilic N, Doench JG, Ly SH, Dai C, Hagel K, Hong AL, Gjoerup O, Goel S, Ge JY, Root DE, Zhao JJ, Brooks AN, Weinberg RA, Hahn WC (2018) An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer. Elife 7:e37184. https:\/\/doi.org\/10.7554\/eLife.37184","journal-title":"Elife"},{"key":"1085_CR46","doi-asserted-by":"publisher","unstructured":"Li D, Hao X, Song Y (2018) Identification of the Key MicroRNAs and the miRNA-mRNA regulatory pathways in prostate cancer by bioinformatics methods. BioMed Res Int 2018:6204128. https:\/\/doi.org\/10.1155\/2018\/6204128","DOI":"10.1155\/2018\/6204128"},{"issue":"1","key":"1085_CR42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/hep.30158","volume":"69","author":"S Li","year":"2019","unstructured":"Li S, Hu Z, Zhao Y, Huang S, He X (2019) Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer. Hepatology (Baltimore MD) 69(1):359\u2013375. https:\/\/doi.org\/10.1002\/hep.30158","journal-title":"Hepatology (Baltimore MD)"},{"key":"1085_CR11","doi-asserted-by":"publisher","unstructured":"Liao X, Yang C, Huang R, Han C, Yu T, Huang K, Liu X, Yu L, Zhu G, Su H, Wang X, Qin W, Deng J, Zeng X, Ye X, Peng T (2018) Identification of potential prognostic long non-coding RNA biomarkers for predicting survival in patients with hepatocellular carcinoma. Cell Physiol Bioch: Int J Exp Cell Physiol Biochem Pharmacol 48(5):1854\u20131869. https:\/\/doi.org\/10.1159\/000492507","DOI":"10.1159\/000492507"},{"issue":"1","key":"1085_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","volume":"40","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu X, Lin C, Jia X, Zhu H, Song J, Zhang Y (2021) Noncoding RNAs regulate alternative splicing in Cancer. J experimental Clin cancer research: CR 40(1):11. https:\/\/doi.org\/10.1186\/s13046-020-01798-2","journal-title":"J experimental Clin cancer research: CR"},{"issue":"7","key":"1085_CR40","doi-asserted-by":"publisher","first-page":"e0131421","DOI":"10.1371\/journal.pone.0131421","volume":"10","author":"E Mampaey","year":"2015","unstructured":"Mampaey E, Fieuw A, Van Laethem T, Ferdinande L, Claes K, Ceelen W, Van Nieuwenhove Y, Pattyn P, De Man M, De Ruyck K, Van Roy N, Geboes K, Laurent S (2015) Focus on 16p13.3 Locus in Colon Cancer. PLoS ONE 10(7):e0131421. https:\/\/doi.org\/10.1371\/journal.pone.0131421","journal-title":"PLoS ONE"},{"issue":"11","key":"1085_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/17460441.2021.1943354","volume":"16","author":"E Nascimento-Gon\u00e7alves","year":"2021","unstructured":"Nascimento-Gon\u00e7alves E, Seixas F, Ferreira R, Cola\u00e7o B, Parada B, Oliveira PA (2021) An overview of the latest in state-of-the-art murine models for prostate cancer. Expert Opin Drug Discov 16(11):1349\u20131364. https:\/\/doi.org\/10.1080\/17460441.2021.1943354","journal-title":"Expert Opin Drug Discov"},{"issue":"5","key":"1085_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12(5):453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat Methods"},{"issue":"1","key":"1085_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/humu.21609","volume":"33","author":"F Piva","year":"2012","unstructured":"Piva F, Giulietti M, Burini AB, Principato G (2012) SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum Mutat 33(1):81\u201385. https:\/\/doi.org\/10.1002\/humu.21609","journal-title":"Hum Mutat"},{"key":"1085_CR51","doi-asserted-by":"crossref","unstructured":"Rajaram M, Zhang J, Wang T, Li J, Kuscu C, Qi H, Kato M, Grubor V, Weil RJ, Helland A, Borrenson-Dale AL, Cho KR, Levine DA, Houghton AN, Wolchok JD, Myeroff L, Markowitz SD, Lowe SW, Zhang M, Krasnitz A, \u2026 Powers RS (2013) Two distinct categories of focal deletions in cancer genomes. PloS one 8(6):e66264. 10.1371\/journal.pone.0066264","DOI":"10.1371\/journal.pone.0066264"},{"key":"1085_CR30","doi-asserted-by":"publisher","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) Bioinf (Oxford England) 26(1):139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","DOI":"10.1093\/bioinformatics\/btp616"},{"issue":"379","key":"1085_CR39","doi-asserted-by":"publisher","first-page":"eaah3560","DOI":"10.1126\/scitranslmed.aah3560","volume":"9","author":"W Roh","year":"2017","unstructured":"Roh W, Chen PL, Reuben A, Spencer CN, Prieto PA, Miller JP, Gopalakrishnan V, Wang F, Cooper ZA, Reddy SM, Gumbs C, Little L, Chang Q, Chen WS, Wani K, De Macedo MP, Chen E, Austin-Breneman JL, Jiang H, Roszik J, Futreal PA (2017) Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci Transl Med 9(379):eaah3560. https:\/\/doi.org\/10.1126\/scitranslmed.aah3560","journal-title":"Sci Transl Med"},{"issue":"D1","key":"1085_CR27","doi-asserted-by":"publisher","first-page":"D1018","DOI":"10.1093\/nar\/gkv1288","volume":"44","author":"M Ryan","year":"2016","unstructured":"Ryan M, Wong WC, Brown R, Akbani R, Su X, Broom B, Melott J, Weinstein J (2016) TCGASpliceSeq a compendium of alternative mRNA splicing in cancer. Nucleic Acids Res 44(D1):D1018\u2013D1022. https:\/\/doi.org\/10.1093\/nar\/gkv1288","journal-title":"Nucleic Acids Res"},{"key":"1085_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/PGPM.S348565","volume":"15","author":"VH Schitcu","year":"2022","unstructured":"Schitcu VH, Raduly L, Nutu A, Zanoaga O, Ciocan C, Munteanu VC, Cojocneanu R, Petrut B, Coman I, Braicu C, Berindan-Neagoe I (2022) MicroRNA Dysregulation in Prostate Cancer. Pharmacogenomics personalized Med 15:177\u2013193. https:\/\/doi.org\/10.2147\/PGPM.S348565","journal-title":"Pharmacogenomics personalized Med"},{"key":"1085_CR15","doi-asserted-by":"publisher","unstructured":"Sciarrillo R, Wojtuszkiewicz A, Assaraf YG, Jansen G, Kaspers GJL, Giovannetti E, Cloos J (2020) The role of alternative splicing in cancer: From oncogenesis to drug resistance. Drug Resist Updates: Rev Commentaries Antimicrob Anticancer Chemother 53:100728. https:\/\/doi.org\/10.1016\/j.drup.2020.100728","DOI":"10.1016\/j.drup.2020.100728"},{"key":"1085_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-12-1","volume":"12","author":"N Sengupta","year":"2013","unstructured":"Sengupta N, Yau C, Sakthianandeswaren A, Mouradov D, Gibbs P, Suraweera N, Cazier JB, Polanco-Echeverry G, Ghosh A, Thaha M, Ahmed S, Feakins R, Propper D, Dorudi S, Sieber O, Silver A, Lai C (2013) Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion. Mol Cancer 12:1. https:\/\/doi.org\/10.1186\/1476-4598-12-1","journal-title":"Mol Cancer"},{"issue":"1","key":"1085_CR59","doi-asserted-by":"publisher","first-page":"BSR20201533","DOI":"10.1042\/BSR20201533","volume":"41","author":"J Song","year":"2021","unstructured":"Song J, Wang W, Yuan Y, Ban Y, Su J, Yuan D, Chen W, Zhu J (2021) Identification of immune-based prostate cancer subtypes using mRNA expression. Biosci Rep 41(1):BSR20201533. https:\/\/doi.org\/10.1042\/BSR20201533","journal-title":"Biosci Rep"},{"issue":"3","key":"1085_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/14789450.2016.1136217","volume":"13","author":"Y Subbannayya","year":"2016","unstructured":"Subbannayya Y, Pinto SM, Gowda H, Prasad TS (2016) Proteogenomics for understanding oncology: recent advances and future prospects. Expert Rev Proteomics 13(3):297\u2013308. https:\/\/doi.org\/10.1586\/14789450.2016.1136217","journal-title":"Expert Rev Proteomics"},{"issue":"D1","key":"1085_CR31","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","volume":"45","author":"D Szklarczyk","year":"2017","unstructured":"Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45(D1):D362\u2013D368. https:\/\/doi.org\/10.1093\/nar\/gkw937","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1085_CR55","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.1038\/s41467-025-62172-4","volume":"16","author":"S Tejay","year":"2025","unstructured":"Tejay S, Lorenzana-Carrillo MA, Huang G, Tabatabaei Dakhili SA, Zhao Y-, Eaton F, Mendiola Pla M, Bowles DE, Kinnaird A, Paterson DI, Pituskin E, Ussher JR, Michelakis ED, Sutendra G (2025) Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents. Nat Commun 16(1):6861. https:\/\/doi.org\/10.1038\/s41467-025-62172-4","journal-title":"Nat Commun"},{"issue":"1","key":"1085_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12864-016-3029-z","volume":"17","author":"MP Tremblay","year":"2016","unstructured":"Tremblay MP, Armero VE, Allaire A, Boudreault S, Martenon-Brodeur C, Durand M, Lapointe E, Thibault P, Tremblay-L\u00e9tourneau M, Perreault JP, Scott MS, Bisaillon M (2016) Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma. BMC Genomics 17(1):683. https:\/\/doi.org\/10.1186\/s12864-016-3029-z","journal-title":"BMC Genomics"},{"issue":"8","key":"1085_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.trecan.2020.04.011","volume":"6","author":"E Wang","year":"2020","unstructured":"Wang E, Aifantis I (2020) RNA Splicing and Cancer. Trends cancer 6(8):631\u2013644. https:\/\/doi.org\/10.1016\/j.trecan.2020.04.011","journal-title":"Trends cancer"},{"key":"1085_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/978-0-387-77374-2_3","volume":"623","author":"Y Xing","year":"2007","unstructured":"Xing Y, Lee C (2007) Relating alternative splicing to proteome complexity and genome evolution. Adv Exp Med Biol 623:36\u201349. https:\/\/doi.org\/10.1007\/978-0-387-77374-2_3","journal-title":"Adv Exp Med Biol"},{"issue":"Database issue","key":"1085_CR36","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR, Ramaswamy S, Futreal PA, Haber DA, Stratton MR, Benes C, McDermott U, Garnett MJ (2013) Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41(Database issue):D955\u2013D961. https:\/\/doi.org\/10.1093\/nar\/gks1111","journal-title":"Nucleic Acids Res"},{"issue":"40","key":"1085_CR5","doi-asserted-by":"publisher","first-page":"6678","DOI":"10.1038\/s41388-019-0910-7","volume":"38","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yan L, Zeng J, Zhou H, Liu H, Yu G, Yao W, Chen K, Ye Z, Xu H (2019) Pan-cancer analysis of clinical relevance of alternative splicing events in 31 human cancers. Oncogene 38(40):6678\u20136695. https:\/\/doi.org\/10.1038\/s41388-019-0910-7","journal-title":"Oncogene"},{"issue":"17","key":"1085_CR48","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1128\/MCB.00530-08","volume":"28","author":"HL Zhou","year":"2008","unstructured":"Zhou HL, Lou H (2008) Repression of prespliceosome complex formation at two distinct steps by Fox-1\/Fox-2 proteins. Mol Cell Biol 28(17):5507\u20135516. https:\/\/doi.org\/10.1128\/MCB.00530-08","journal-title":"Mol Cell Biol"},{"key":"1085_CR19","doi-asserted-by":"publisher","first-page":"736431","DOI":"10.3389\/fonc.2021.736431","volume":"11","author":"L Zhou","year":"2021","unstructured":"Zhou L, Zhang C, Zhang Y, Shi C (2021) Application of Organoid Models in Prostate Cancer Research. Front Oncol 11:736431. https:\/\/doi.org\/10.3389\/fonc.2021.736431","journal-title":"Front Oncol"},{"issue":"2","key":"1085_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ygyno.2017.11.028","volume":"148","author":"J Zhu","year":"2018","unstructured":"Zhu J, Chen Z, Yong L (2018) Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer. Gynecol Oncol 148(2):368\u2013374. https:\/\/doi.org\/10.1016\/j.ygyno.2017.11.028","journal-title":"Gynecol Oncol"},{"issue":"9","key":"1085_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/carcin\/bgz073","volume":"40","author":"GQ Zhu","year":"2019","unstructured":"Zhu GQ, Zhou YJ, Qiu LX, Wang B, Yang Y, Liao WT, Luo YH, Shi YH, Zhou J, Fan J, Dai Z (2019) Prognostic alternative mRNA splicing signature in hepatocellular carcinoma: a study based on large-scale sequencing data. Carcinogenesis 40(9):1077\u20131085. https:\/\/doi.org\/10.1093\/carcin\/bgz073","journal-title":"Carcinogenesis"}],"container-title":["Journal of Applied Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-026-01085-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13353-026-01085-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13353-026-01085-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T02:56:16Z","timestamp":1781319376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13353-026-01085-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":59,"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1007\/s13353-026-01085-4","relation":{},"ISSN":["1234-1983","2190-3883"],"issn-type":[{"value":"1234-1983","type":"print"},{"value":"2190-3883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}